LENZ
LENZ Therapeutics, Inc.
+0.02 (+0.36%)4.16USD264K成交股數131M市值–本益比(近四季)6.1股價營收比+9.7%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 5.5M+10% | 1.9M | 1.6M | 12.5M | 5.0M | 0 | 0 | 0 | – | – | – | – |
| 營業成本 | 280K | 1.1M | – | – | 0 | 0 | – | – | – | – | – | – |
| 毛利 | 5.2M+4% | 825K | – | – | 5.0M | 0 | – | – | – | – | – | – |
| 毛利率 | 94.9% | 43.4% | – | – | 100.0% | – | – | – | – | – | – | – |
| 研發費用 | 0 | 0 | 0 | 3.8M | 9.1M | 5.8M | 6.5M | 6.9M | 10.5M | 19.5M | 17.0M | 12.6M |
| 銷售管理費用 | 39.4M | 45.0M | 39.6M | 27.6M | 12.8M | 11.1M | 6.5M | 7.4M | 5.6M | 5.5M | 2.9M | 2.3M |
| 營業利益 | −34.2M+103% | −44.1M+161% | −38.5M+197% | −18.9M+32% | −16.9M+5% | −16.9M-32% | −12.9M-35% | −14.4M-4% | −16.1M | −25.0M | −19.9M | −15.0M |
| 營業利益率 | -622.9% | -2,321.7% | -2,422.1% | -151.1% | -337.1% | – | – | – | – | – | – | – |
| 稅後淨利 | −31.9M+114% | −41.5M+184% | −35.9M+251% | −16.7M+63% | −14.9M-10% | −14.6M-38% | −10.2M-46% | −10.3M-30% | −16.6M | −23.7M | −18.9M | −14.7M |
| 淨利率 | -581.8% | -2,182.4% | -2,260.5% | -133.6% | -298.2% | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.02+92% | -1.32+149% | -1.20+216% | -0.59+47% | -0.53-85% | -0.53-96% | -0.38-96% | -0.40-95% | -3.53 | -12.06 | -9.62 | -7.53 |
| 稀釋股數 | 31.4M | 31.4M | 28.8M | 28.5M | 28.1M | 27.5M | 27.2M | 25.6M | 4.7M | 2.0M | 2.0M | 2.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.2M | 24.8M | 25.2M | 25.4M | 37.6M | 23.0M | 41.0M | 84.0M | 200M | 35.1M | 183M | 129M |
| 應收帳款 | 442K | 343K | 329K | – | – | – | – | – | – | – | – | – |
| 存貨 | 4.1M | 3.5M | 2.9M | 949K | – | – | – | – | – | – | – | – |
| 總資產 | 237M | 273M | 306M | 211M | 217M | 201M | 224M | 203M | 217M | 70.4M | 266M | 287M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 17.3M | 26.0M | 21.5M | 16.8M | 11.0M | 9.2M | 8.7M | 9.7M | 19.2M | 19.7M | 62.2M | 62.9M |
| 股東權益 | 219M | 246M | 284M | 194M | 206M | 192M | 215M | 193M | 198M | −92.7M | −69.6M | −51.2M |
| 負債比 | 7.3% | 9.6% | 7.0% | 8.0% | 5.0% | 4.6% | 3.9% | 4.8% | 8.8% | 28.0% | 23.4% | 21.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −33.6M+109% | – | – | – | −16.0M | – | – | −23.9M | – | – | – |
| 資本支出 | – | 18K | – | – | – | 110K | – | – | 0 | – | – | – |
| 自由現金流 | – | −33.6M+108% | – | – | – | −16.2M | – | – | −23.9M | – | – | – |
| 折舊攤銷 | – | 111K | – | – | – | 36K | – | – | 5K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1,767.5% | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 19.1M
| License | 17.5M | 91.7% | – |
|---|---|---|---|
| 產品 | 1.6M | 8.3% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 19.1M | – | −82.1M | -430.3% | -2.85 | −70.0M |
| FY2024 | 0 | – | −49.8M | –% | -2.34 | −59.9M |
| FY2023 | – | – | −70.0M | –% | -35.71 | −60.4M |
| FY2022 | – | – | −101M | –% | -1.84 | −94.6M |
| FY2021 | – | – | −70.8M | –% | -2.45 | −58.6M |
| FY2020 | – | – | −68.4M | –% | -29.93 | −10.3M |